Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFMW) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Sunshine Biopharma (SBFMW) over the last 12 years, with Q3 2025 value amounting to $253.0.

  • Sunshine Biopharma's Other Non Operating Income fell 9833.04% to $253.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$337359.0, marking a year-over-year decrease of 21401.81%. This contributed to the annual value of -$44082.0 for FY2024, which is 1789265.31% down from last year.
  • Sunshine Biopharma's Other Non Operating Income amounted to $253.0 in Q3 2025, which was down 9833.04% from $1940.0 recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Other Non Operating Income ranged from a high of $286535.0 in Q2 2024 and a low of -$340003.0 during Q4 2024
  • Over the past 5 years, Sunshine Biopharma's median Other Non Operating Income value was $130.5 (recorded in 2021), while the average stood at $1123.1.
  • Within the past 5 years, the most significant YoY rise in Sunshine Biopharma's Other Non Operating Income was 10988352.49% (2024), while the steepest drop was 87170256.41% (2024).
  • Quarter analysis of 5 years shows Sunshine Biopharma's Other Non Operating Income stood at -$7909.0 in 2021, then surged by 100.32% to $25.0 in 2022, then tumbled by 256.0% to -$39.0 in 2023, then plummeted by 871702.56% to -$340003.0 in 2024, then skyrocketed by 100.07% to $253.0 in 2025.
  • Its Other Non Operating Income stands at $253.0 for Q3 2025, versus $1940.0 for Q2 2025 and $451.0 for Q1 2025.